Clover Health Investments, CORP /DE Form 4 insider transactions

Clover Health's Chief Financial Officer, Peter J. Kuipers, reported a disposition of 217,382 shares of Class A Common Stock due to tax withholding upon the vesting of restricted stock units.

Conrad Wai, CEO of Counterpart Health, a subsidiary of Clover Health Investments, Corp., has scheduled the sale of over 200,000 Class A Common Stock shares in July 2025 under a pre-arranged trading plan.

Clover Health's CEO of Home Care, Brady Priest, amended a Form 4 filing to clarify the full achievement and vesting of performance-based restricted stock units.

Clover Health Investments, Corp. CEO Conrad Wai filed an amended Form 4 detailing the vesting of performance-based restricted stock units and a future sale of shares under a pre-arranged trading plan.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold a total of 21,801 Class A Common Stock shares and had 8,706 shares withheld for tax obligations in early July 2025, all under a Rule 10b5-1 trading plan.

Clover Health Investments, Corp. CEO Andrew Toy reported the automatic withholding of 308,950 Class A Common Stock shares to cover tax obligations related to the vesting of restricted stock units.

Clover Health Investments Corp. CEO of Medicare Advantage, Jamie L. Reynoso, reported the future vesting of 217,523 restricted stock units and the simultaneous disposition of 85,596 shares for tax purposes, effective June 30, 2025.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 20,450 shares of Class A Common Stock for a weighted average price of $2.86 per share, pursuant to a Rule 10b5-1 trading plan.

Clover Health Investments, Corp.'s General Counsel and Secretary, Karen Soares, reported the disposition of 6,404 Class A Common Stock shares on June 15, 2025, to cover tax obligations related to RSU vesting.

Clover Health Investments Corp. CEO Conrad Wai disposed of 98,411 Class A Common Stock shares on June 14, 2025, to cover tax obligations related to the vesting of restricted stock units.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., reported the disposition of Class A Common Stock shares to cover tax obligations related to the vesting of restricted stock units.

Clover Health's CFO, Peter Kuipers, reports the acquisition of restricted stock units (RSUs) that will vest over time, according to a Form 4 filing.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of 5,345 shares of Class A Common Stock to cover tax obligations upon RSU vesting.

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, disposed of 27,293 shares of Class A Common Stock on April 30, 2025, to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health (a division of Clover Health Investments), reports the disposal of 26,593 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units.

Clover Health CEO Jamie Reynoso sold 25,659 shares of Class A Common Stock on April 30, 2025, to cover tax obligations related to the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health Investments, disposed of 25,080 shares of Class A Common Stock to cover tax obligations upon vesting of restricted stock units.

Clover Health's CFO, Peter Kuipers, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Brady Priest, CEO of Home Care at Clover Health, disposed of shares to cover tax obligations upon the vesting of restricted stock units.

Jamie Reynoso, CEO of Clover Health, reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations arising from the vesting of restricted stock units.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

CEO of Clover Health, Jamie Reynoso, disposed of shares to cover tax obligations related to vesting restricted stock units.

Conrad Wai, CEO of Counterpart Health and an officer of Clover Health Investments, sold shares to cover tax obligations upon the vesting of restricted stock units.

Director Carladenise Edwards sold 200,000 shares of Clover Health Investments, CORP. on March 7, 2025, at an average price of $3.61 per share.

Clover Health's CEO of Home Care, Brady Patrick Priest, sold 75,000 shares of Class A Common Stock at an average price of $3.68 on March 6, 2025.

Karen Soares, General Counsel & Secretary of Clover Health Investments, sold 52,500 shares of Class A Common Stock on March 6, 2025, at a price of $3.8 per share.

Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the disposal of shares to cover tax obligations upon vesting of restricted stock units.

Andrew Toy, CEO of Clover Health, disposed of shares to cover tax obligations related to the vesting of restricted stock units.